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Case Reportsof small vegetations (<3 mm), recent embolization,
nonoscillating or atypically located vegetations, or difficult
to identify IE lesions in the setting of preexisting cardiac
lesions (mitral prolapse, prosthetic valves, intracardiac
devices, degenerative or sclerotic valves).3 Although the
combination of negative TTE and TEE study results
provides a 95% negative predictive value, such results do
not definitively rule out vegetative IE.4 Current guidelines
recommend repeating TEE imaging in 7 to 10 days if
clinical suspicion remains high in the setting of an initial
negative echocardiographic interpretation.1,2 In this
report, an aggressive valvular infection with local tissue
destruction developed within only 7 days. With a growing
body of evidence supporting early surgical intervention in
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e28 The Journal of Thoracic and Cardiovascular Surgechocardiographic imaging, because earlier identification
of the severity of infection might have prompted earlier
surgical intervention and potentially yielded an improved
surgical outcome.
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high-pressure pulmonoplegia
Nikhil Prakash Patil, MRCS, MCh, Prashant N. Mohite, MRCS, MCh, Andre R. Simon, MD, PhD, and
Mohamed Amrani, MD, PhD, London, United KingdomShortage of organ donors results in significant mortality
among patients on transplant waiting lists, necessitating
thorough evaluation before declining potentially transplant-
able organs. We report a case in which donor lung
pulmonoplegia was accidentally delivered under high
pressure. Despite a potential risk from elevated flushing
pressures, the lungs were successfully transplanted after
assessment with ex vivo lung perfusion (EVLP).1,2CLINICAL SUMMARY
Lungs from a 35-year-old female multiorgan donor with
brainstem death after intracranial hemorrhage were
provisionally accepted for a 52-year-old male patient with
pulmonary fibrosis who was on our waiting list. Blood
gas values at the time of organ offer showed a ratio of
PaO2 to inspired oxygen fraction greater than 300; all other
parameters were acceptable.Organ retrieval entailed median sternotomy and
satisfactory on-table assessment, including pulmonary
vein gas values. After bicaval ligation and aortic clamping,
the right atrium and left atrial appendage were incised for
venting while the lungs were flushed with 50-mL/kg cold
Perfadex solution (Vitrolife AB, G€oteborg, Sweden).
Inadvertently, the pulmonary artery was perfused at very
high pressures (pressure gauge reading >150 mm Hg),
and the error was noticed only after 2 to 3 minutes (almost
all pulmonoplegia delivered). Because of the possibility of
alveolocapillary damage in the pulmonary vascular bed, it
was decided not to transplant the lungs directly; rather,
the donor lungs were evaluated with EVLP to assess
suitability for implantation.
After returning to our center, the organs were trans-
ferred to the XVIVO Organ Chamber (Vitrolife) and as-
sessed during ex vivo perfusion with STEEN solution
(Vitrolife) as described elsewhere.1 Briefly, the procedure
entails cannulation of the left atrial cuff and main pulmo-
nary artery, tracheal intubation, and ex vivo perfusion with
an acellular perfusate under controlled temperature,
pressure, and ventilation parameters to mimic physiologic
conditions. Both at the beginning and after completion
of EVLP, functional parameters such as oxygenation
difference (pulmonary vein PO2  pulmonary artery
PO2), pulmonary vascular resistance, dynamic lung
compliance, and airway pressures were found to be
acceptable. Consequently, the lungs were deemed to
be suitable for transplantation and implanted withery c March 2014
Case Reportscardiopulmonary bypass, with an excellent size match
with the recipient.
Postoperative bronchoscopy showed moderate mucosal
inflammation with intact anastomoses. The recipient
was extubated after 5 days, transferred to the ward on day
10 and discharged on day 22. He continues to do well
8 months postoperatively, with satisfactory chest radiog-
raphy, blood gas evaluation, and spirometry results.
DISCUSSION
Despite the shortage of organ donors, only 17% of donor
lungs in the United States and 15% in the United Kingdom
are used for transplantation, with ‘‘poor function’’ cited as
the causeof 60%ofdonor organ rejections inNorthAmerica.1
Organ retrieval often involves thoracic and abdominal
teams sharing operating space and working ‘‘against the
clock.’’ Nevertheless, errors may have untoward conse-
quences, such as the accidental delivery of pulmonoplegia
at high pressure in this report. It is well established that
high flow induces pulmonary vasculopathy as a result of
high pressure and high shear stress with time,3 and flushing
pressures lower than 20 mm Hg have been advocated for
lung preservation.4 Assessment of lungs in a multiorgan
donor is limited, however, by the necessity to maintain
sufficient circulation and oxygen delivery to the other organ
systems. In addition, there are no specific data on whether
lungs subjected to excessive perfusion pressure sustain
significant vascular barotrauma and whether such lungs can
be successfully transplanted. The influence of high-pressure
pulmonoplegia onprimary graft dysfunction is alsounknown,
and the consequent risk oforgan failure in the recipient cannot
be quantified. Because of the scarcity of available organs and
the fact that all preretrieval parameters were excellent, we
decided to evaluate the lungs with EVLP. In this case,
EVLP assessment of lung viability was satisfactory despite
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tions for the successful outcome include (1) inaccurate
monitoring, with a low actual flushing pressure (unlikely);
(2) incision of the left atrial appendage facilitates
unobstructed drainage of perfusate, limiting the effect of hy-
pertension in the pulmonary vascular bed; (3) the physiologic
insult of very brief high flushing pressures is minimal; and
(4) EVLP mitigated the insult and optimized the lungs for
transplantation. EVLP can cost roughly £1500 to £2000
onward (costs may vary by center and country); however,
there is some evidence that that lungs initially rejected for
donation because of impaired function can be improved
during EVLP and eventually transplanted without compro-
mising early clinical results.5
CONCLUSIONS
High-pressure pulmonoplegia may not adversely
impact donor lungs sufficiently to preclude transplantation.
Our patient continues to do well 8 months postoperatively,
pending longer-term follow-up. EVLP may possibly
help to evaluate the transplant potential of donor lungs in
doubtful cases.
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J Thorac Cardiovasc Surg. 2012;144:1222-8.Cardiac allograft failure: Retransplant or long-term ventricular
assist device?
Tomohiro Saito, MD, Nicola Hiemann, MD, PhD, Thomas Krabatsch, MD, PhD,
Evgenij Potapov, MD, PhD, and Roland Hetzer, MD, PhD, Berlin, GermanyIn determining treatment for cardiac allograft failure, one
consideration is that outcomes after cardiac retransplants
have been reported to be inferior to those observed after
primary transplants.1 In addition, the ethical dimension of
the issue makes it difficult to reach a complete consensus.
We report implantation of a left ventricular assist device
for long-term support in a patient with cardiac allograft
failure caused by coronary allograft vasculopathy.rdiovascular Surgery c Volume 147, Number 3 e29
